These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7294975)
21. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. Ault KA; Springer TA J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976 [TBL] [Abstract][Full Text] [Related]
22. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis. Chen Z; Freedman MS Clin Immunol; 2008 Aug; 128(2):219-27. PubMed ID: 18501678 [TBL] [Abstract][Full Text] [Related]
23. The cellular nature of concanavalin A-stimulated antibody-dependent cell-mediated cytotoxicity. Connolly JM; Wunderlich JR J Immunol; 1980 Apr; 124(4):1917-23. PubMed ID: 7365243 [TBL] [Abstract][Full Text] [Related]
24. Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients. Merrill JE; Wåhlin B; Sidén A; Perlmann P J Immunol; 1982 Apr; 128(4):1728-35. PubMed ID: 7037955 [No Abstract] [Full Text] [Related]
25. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related]
26. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species. Cortens M; Sklar S; Richter M Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704 [TBL] [Abstract][Full Text] [Related]
27. Role of natural killer and killer cells in concordant xenograft rejection. Patselas T; Thomas F; Araneda D; Marchman W Transplant Proc; 1995 Feb; 27(1):262-3. PubMed ID: 7878995 [TBL] [Abstract][Full Text] [Related]
28. Inactivation of natural killer cell cytotoxic activity after interaction with target cells. Perussia B; Trinchieri G J Immunol; 1981 Feb; 126(2):754-8. PubMed ID: 7451993 [TBL] [Abstract][Full Text] [Related]
29. Conjugate formation between effector and target as a function of cytotoxicity in antibody-dependent killing of AK-5 tumor. Kausalya S; Pardhasaradhi BV; Manogaran PS; Khar A Indian J Exp Biol; 1995 Mar; 33(3):161-4. PubMed ID: 7601484 [TBL] [Abstract][Full Text] [Related]
30. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes. Sharland A; Lee JH; Saidman S; Waneck GL Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534 [TBL] [Abstract][Full Text] [Related]
32. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686 [TBL] [Abstract][Full Text] [Related]
33. Natural killing and antibody-dependent cytotoxicity by T leukaemic blasts from acute lymphoblastic leukaemia. Gupta S; Fernandes G Scand J Immunol; 1982 Dec; 16(6):477-80. PubMed ID: 6984221 [TBL] [Abstract][Full Text] [Related]
34. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
35. [Functional characteristics and clinical importance of the K cells (a review of the literature)]. Drannik GN; Mitchenko EI; Ena IaM; Gritsenko NI Vrach Delo; 1982 Nov; (11):17-21. PubMed ID: 6760548 [No Abstract] [Full Text] [Related]
36. Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors. Voltarelli JC; Gjerset G; Anasetti C Immunology; 1993 Jul; 79(3):509-11. PubMed ID: 8104886 [TBL] [Abstract][Full Text] [Related]
37. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412 [TBL] [Abstract][Full Text] [Related]
38. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo. Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990 [TBL] [Abstract][Full Text] [Related]
39. The antibody-dependent cell-mediated cytotoxic reaction. II. The effect of the concentration of anti-target cell antibodies on the identity of the human effector cells. Keaney M; McPhail S; Jodouín CA; Richter M Immunology; 1980 Jun; 40(2):205-10. PubMed ID: 7409857 [TBL] [Abstract][Full Text] [Related]
40. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]